On July 8, 2019, Scott M. Coiante, Agile Therapeutics, Inc.'s senior Vice President and Chief Financial Officer, informed the company that he has accepted a position with a private company. Mr. Coiante will be departing the company after the filing of the company's quarterly report on Form 10-Q for the period ending June 30, 2019. After his departure, Mr. Coiante will be available to assist the company to support a smooth transition of his roles and responsibilities through December 31, 2019.

The company has initiated a search for his successor. Joseph D'Urso, the company's Controller, will serve as the Company's interim principal accounting and principal financial officer after Mr. Coiante leaves the Company while the Company completes its search for a permanent Chief Financial Officer. Mr. Coiante's decision to depart from the Company is solely for personal reasons and does not reflect any disagreement with the Company.